Operating profit before deduction of amortization: Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics (ACRS) brings together top immunologists whose research requires a stable budget. The price action on the GURU.Markets chart confirms volatility, where the base EBITDA level forms consolidation corridors, and the value of 0.00 shows the current magnitude. To stabilize, Aclaris Therapeutics is diversifying molecules across various pathologies while simultaneously shifting toward conservative capital management and the licensing of early-stage developments.
aclaristx.com (ACRS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Aclaris Therapeutics|ACRS - Long-Term Debt to Capital|Current Liabilities to Capital Aclaris|ACRS - Company Aggregate Debts|Debts to Book Capitalization Aclaris Therapeutics, Inc.|ACRS - Company Long-Term Debts|Company Current Liabilities Aclaris Therapeutics|Quick Liquidity aclaristx.com
- earnings and multiples data:
ACRS - Net Profit|Projected Future Earnings Aclaris Therapeutics|ACRS - Price to Earnings Ratio|Future Price to Earnings Multiple Aclaris Therapeutics, Inc.|ACRS - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aclaris Therapeutics Inc.|ACRS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Aclaris Therapeutics|ACRS - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months aclaristx.com|ACRS - Net earnings per share growth this year|Projected earnings per share increase next year Aclaris Therapeutics
- sales and revenue indicators:
Summary company analytics:ACRS (Aclaris Therapeutics)
Aclaris Therapeutics (ACRS) is currently undergoing a phase of radical resource optimization, reducing headcount and revising its asset ownership strategy. By analyzing operating earnings dynamics, investors can identify the actual cash flow from core operations excluding one-off factors, which allows for an assessment of price stability amid molecule licensing and the absence of new M&A deals.
Who Aclaris Therapeutics competes with
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Kyverna - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization TLSA|Profit before interest, taxes and amortization Cabaletta Bio CABA|Operating profit EBITDA VTYX|Theratechnologies (THTX) - Operating profit before depreciation charges|Avalo Therapeutics - Operating profit before deduction of amortization|Eledon Pharmaceuticals (ELDN) - Profit before interest, taxes and amortization|Agenus, Inc - Operating profit EBITDA|Profit before interest, taxes and amortization climbbio.com|ZURA (Zura Bio Limited) - Operating profit before deduction of amortization|aTyr (ATYR) - Operating profit EBITDA|Operating profit before deduction of amortization ADAG|IMA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Shattuck Therapeutics (STTK)|Operating profit before deduction of amortization Equillium EQ|Connect Biopharma Holdings Limited - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMUX|ATRA - Profit before payment of interest, taxes and amortization|inflarx.de (IFRX) - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization X4 Pharmaceuticals XFOR|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization celularity.com|INMB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc (KZR)|Operating profit EBITDA SABS (SAB Biotherapeutics)|Operating profit EBITDA akaritx.com AKTX|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
